Alexis DeSieno - Mar 19, 2025 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Financial Officer
Signature
/s/ Nick Lynton, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Mar 19, 2025
Transactions value $
$0
Form type
4
Date filed
3/21/2025, 08:54 PM
Previous filing
Feb 18, 2025
Next filing
Apr 3, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Performance Stock Unit Award $0 +50.6K $0.00 0 Mar 19, 2025 Common Stock 50.6K Direct F1, F2
transaction CDLX Restricted Stock Unit Award $0 +135K $0.00 0 Mar 19, 2025 Common Stock 135K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F4 50% of the shares underlying the RSU award will vest on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.